ILEX Oncology (ILXO)
ILEX Oncology Inc. is a drug development company focused predominantly on the accelerated development of drugs for the treatment and prevention of cancer. The company does this in two ways: by advancing a diversified portfolio of anti-cancer drugs through its ILEX Products subsidiary, and, by offering drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary. (PRESS RELEASE)
Address
4545 Horizon Hill Blvd.
San Antonio, TX 78229
(210) 949-8200
http://www.ilexonc.com/
Top Executives
Gary Woods, Chairman
Jeffrey Buchalter, President
Mark Mellin, CFO
Timothy Ruane, Senior VP
Craig Tooman, Senior VP
Exchange:
Nasdaq
Size:
Small-Cap
SIC Code:
8731
Competitors:
IDEC Pharmaceuticals
,
Protein Design Labs
,
Medarex
,
Cell Therapeutics
,
NeoRx
,
Bone Care International
InvestorGuide Research Links
Stock:
ILEX Oncology
Sector:
Services
Industry:
Commercial physical research
Special Offers
Buy ILXO for just $4
Give this profile a rating from 1 to 5 (5 being the best)...
1
2
3
4
5
Buy ILEX Oncology for just $4
www.sharebuilder.com
Trading Currencies Can Be Easy As 1, 2, 3 - Try a Free Practice Account Today.
www.ac-markets.com
See Your Message Here
Browse by Letter:
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
